cyclosporine has been researched along with Infectious Keratoconjunctivitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gordon, YJ; Pless, P; Romanowski, EG; Yates, KA | 1 |
| Hillenkamp, J; Reinhard, T; Sundmacher, R | 1 |
1 review(s) available for cyclosporine and Infectious Keratoconjunctivitis
| Article | Year |
|---|---|
[Prospects for therapy and prevention of adenovirus keratoconjunctivitis].
Topics: Adenovirus Infections, Human; Adolescent; Adrenal Cortex Hormones; Adult; Antiviral Agents; Child; Child, Preschool; Cidofovir; Cyclosporine; Cytosine; Humans; Immunosuppressive Agents; Interferons; Keratitis; Keratoconjunctivitis, Infectious; Ophthalmic Solutions; Organophosphonates; Organophosphorus Compounds; Recurrence; Time Factors | 2001 |
1 other study(ies) available for cyclosporine and Infectious Keratoconjunctivitis
| Article | Year |
|---|---|
Topical cyclosporine A inhibits subepithelial immune infiltrates but also promotes viral shedding in experimental adenovirus models.
Topics: Adenovirus Infections, Human; Adenoviruses, Human; Administration, Topical; Animals; Chemotaxis, Leukocyte; Cyclosporine; Disease Models, Animal; Epithelium, Corneal; Female; Immunosuppressive Agents; Keratoconjunctivitis, Infectious; Ophthalmic Solutions; Rabbits; T-Lymphocytes; Virus Replication; Virus Shedding | 2005 |